This site is intended for Healthcare Professionals only.

PSNI announces option to pay retention fees in instalments

Date:

Share post:

The Pharmaceutical Society NI (PSNI) has announced plans to facilitate the payment of retention fees by quarterly instalments, beginning June 2024.

Last year, discontent with the burden of the cost of professional retention fees was communicated directly with the Pharmacists Defence Association (PDA) National Officer for Northern Ireland, Una O’Farrell.

The association quickly took action on the comments received and issued a survey to members who are PSNI registrants, seeking their views as a collective.

The survey revealed that 97 per cent of members responding to the survey felt the fees were too high. 80 per cent of members surveyed would opt to pay in instalments if this option were available to them.

On average, the fees accounted for 23 per cent of a pharmacist’s take-home pay for one month.

The PDA presented these findings to the newly appointed chief executive and president of PSNI, who collaborated to find ways to alleviate this burden on pharmacists.

The association said: “The PDA is pleased to note that as an action of that meeting, the PSNI has listened to what pharmacists have said. This option to spread the cost brings the profession into line with peers, and the PDA is proud to have played a part in making this change on pharmacists behalf.

The PDA encourages all members to bring issues like this forward to representatives, networks and national officers, to inform future campaigning on pharmacists behalf.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Haleon to close Maidenhead manufacturing site affecting 435 jobs

Despite the closure, Haleon will retain its presence in the UK with corporate offices in Weybridge and London Haleon,...

UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro amidst escalating competition

Obesity experts raise concern that retail marketing of weight-loss drugs could trivialise their side-effects   British pharmacies and slimming...

MHRA says many online pharmacies are ‘unregulated’,’ illegal’, or ‘fraudulent’

MHRA's latest initiative aims to empower consumers in the fight against online pharmacy frauds The Medicines and Healthcare products...

MHRA outlines strategic approach to AI regulation in healthcare for patient safety

MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity In a...